Intracellular oxidation/reduction status in the regulation of transcription factors NF-κB and AP-1

Toxicology Letters

Volumn 106, Issue 2-3, 1999, Pages 93-106

  Gius, David ^a   Botero, Ana ^a   Shah, Sunita ^a   Curry, Heather A ^a  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

AP 1; Intracellular oxidation reduction status; NF B; Transcription factors

Indexed keywords

1,10 PHENANTHROLINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; AUROTHIOGLUCOSE; BUTYLATED HYDROXYANISOLE; CHELATING AGENT; CYSTEINE; DEFEROXAMINE; DIETHYLDITHIOCARBAMIC ACID; DISULFIRAM; GLUTATHIONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MERCAPTOETHANOL; NORDIHYDROGUAIARETIC ACID; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ADAPTATION; CELL DIFFERENTIATION; CELL GROWTH; CELL RESPIRATION; EUKARYOTIC CELL; GENE EXPRESSION; IMMUNITY; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION;

ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; NF-KAPPA B; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS;

EUKARYOTA;

EID: 0032998598     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00024-7     Document Type: Review

References (94)

1. Abate C., Luk D., Curran T. Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains. Mol. Cell. Biol. 11:1991;3624-3632.
2. Angel P., Karin M. The role of Jun, Fos, and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
3. Ares M.P., Kallin B., Eriksson P., Nilsson J. Oxidized LDL induces transcription factor activator protein-l but inhibits activation of nuclear factor-kappa B in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 15:1995;1584-1590.
4. Baeuerle P.A., Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell. 53:1988;211-217.
5. Baeuerle P.A., Baltimore D. NF-κB: 10 years after. Cell. 87:1996;13-20.
6. Baldwin A.S. The NF-κB and I-κB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-681.
7. Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., Baldwin A.S. Jr. I-κB interacts with the nuclear localization sequences of the subunits of NF-κB: a mechanism for cytoplasmic retention. Genes Dev. 6:1992;1899-1913.
8. Besançon F., Atfi A., Gespach C., Cayre Y.E., Bourgeade M.F. Evidence for a role of NF-κB in the survival of hematopoietic cells mediated by interleukin-3 and the oncogenic TEL/platelet-derived growth factor receptor β-fusion protein. Proc. Natl. Acad. Sci. USA. 95:1998;8081-8086.
9. Brockman J.A., Scherer D.C., McKinsey T.A., Hall S.M., Qi X., Lee W.Y., Ballard D.W. Coupling of a signal response domain in the IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol. 15:1995;2809-2818.
10. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of I-κBα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
11. Chiu R., Imagawa M., Imbra R.J., Bockoven J.R., Karin M. Multiple cis- and transacting elements mediate the transcriptional response to phorbol esters. Nature. 329:1987;648-651.
12. Dalton T.P., Li Q., Bittel D., Liang L., Andrews G.K. Oxidative stress activates metal-responsive transcription factor-1 binding activity. Occupancy in vivo of metal response elements in the metallothionein-I gene promoter. J. Biol. Chem. 271:1996;26233-26241.
13. Datta R., Hallahan S.E., Kharbanda S.M., Rubin E., Sherman M.L., Huberman E., Weichselbaum R.R., Kufe D.W. Involvement of reactive oxygen intermediates in the induction of c-Jun gene transcription by ionizing radiation. Biochemistry. 31:1992;8300-8306.
14. Demple B., Amabile-Cuevas C.F. Redux: the control of oxidative stress responses. Cell. 67:1991;837-839.
15. Devary Y., Rosette C., DiDonato J.A., Karin M. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science. 261:1993;1442-1445.
16. DiDonato J.A., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., Karin M. Mapping of the inducible I-κB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1996;1295-1304.
17. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., Packer L. Redox regulation of NF-κB activation. Free Radic. Biol. Med. 22:1997;1115-1126.
18. Franza B.R. Jr., Rauscher III F.J., Josephs S.F., Curran T. The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science. 239:1988;1150-1153.
19. Fujita T., Nolan G.P., Liou H.C., Scott M.L., Baltimore D. The candidate protooncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7:1993;1354-1363.
20. Gius D., Cao X., Rauscher F.J., Cohen D.R., Curran T., Sukhatme V.P. Transcriptional activation and repression by Fos are independent functions: the C-terminus represses immediate-early gene expression via CArG elements. Mol. Cell. Biol. 10:1990;4243-4255.
21. 2 and radiation. J. Bacteriol. 168:1986;1026-1029.
22. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA. 88:1991;3720-3724.
23. Halliwell B., Gutteridge J.M. Free radicals and antioxidant protection: mechanisms and significance in toxicology and disease. Hum. Toxicol. 7:1988;7-13.
24. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186:1990;1-85.
25. Han D., Tritschler H.J., Packer L. a-Lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem. Biophys. Res. Commun. 207:1995;258-264.
26. Haurand M., Flohe L. Kinetic studies on arachidonate 5-lipoxygenase from rat bosophilic leukemia cells. Biol. Chem. Hoppe Seyler. 369:1988;133-142.
27. Hayash T., Ueno Y., Okamoto T. Oxidoreductive regulation of nuclear factor NF-κB: involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268:1993;11380-11388.
28. Henkel T., Zabel U., van Zee K., Muller J.M., Fanning E., Baeuerle P.A. Intramolecular masking of the nuclear location signal and dimerization domain in the precursor for the p50 NF-κB subunit. Cell. 68:1992;1121-1133.
29. Henkel T., Machleidt T., Alkalay I., Dronke M., Ben-Neriah Y., Beauerle P.A. Rapid proteolysis of I-κBa is necessary for activation of transcription factor NF-κB. Nature. 365:1993;182-185.
30. Hill C.S., Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80:1995;199-211.
31. Hirota K., Matsui M., Iwata S., Nishiyama A., Mori K., Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA. 94:1997;3633-3639.
32. Holbrook N.J., Fornace A.J. Response to adversity: molecular control of gene activation following genotoxic stress. New Biologist. 3:1991;825-833.
33. Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 257:1992;1496-1502.
34. Ishii T., Sugita Y., Bannai S. Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J. Cell. Physiol. 133:1987;330-336.
35. Karin M., Hunter T. Transcriptional control by protein phosphorylation: signal transmission from cell surface to the nucleus. Curr. Biol. 5:1995;747-757.
36. Karin M., Smeal T. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17:1992;418-422.
37. Kerppola T.K., Curran T. Transcription. Zen and the art of Fos and Jun. Nature. 373(6511):1995;199-200.
38. Kerr L.D., Inoue J., Verma I.M. Signal transduction: the nuclear target. Curr. Opin. Cell Biol. 4:1992;496-501.
39. Kinscherf R., Fischbach T., Mihm S., Roth S., Hohenhaus-Sievert E., Weiss C., Edler L., Bartsch P., Droge W. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells. FASEB J. 8:1994;448-451.
40. Kullik I., Toledano M.B., Tartaglia L.A., Storz G. Mutational analysis of the redox-sensitive transcriptional regulator OxyR: regions important for oxidation and transcriptional activation. J. Bacteriol. 177:1995;1275-1284.
41. Kullik I., Stevens J., Toledano M.B., Storz G. Mutational analysis of the redox sensitive transcriptional regulator OxyR: regions important for DNA binding and multimerization. J. Bacteriol. 177:1995;1285-1291.
42. Lee F.S., Hagler J., Chen Z.J., Maniatis T. Activation of the I-κB kinase complex by MEKK1, a kinase of the JNK pathway. Cell. 88:1997;213-222.
43. 2 and N-acetyl-L-cysteine regulate expression of c-Jun and c-Fos in lens systems. Exp. Eye Res. 59:1994;179-190.
44. Maity A., Kao G.D., Muschel R.J., McKenna W.G. Potential molecular targets for manipulating the radiation response. Int. J. Rad. Oncol. Biol. Phys. 37:1997;639-653.
45. Makropoulos V., Bruening T., Schulze-Osthoff K. Selenium-mediated inhibition of transcription factor NF-κB and HIV-1 LTR promoter activity. Arch. Toxicol. 70:1996;277-283.
46. McBride K., Nemer M. The C-Terminal domain of c-fos is required for activation of an AP-1 site specific for jun-fos heterodimers. Mol. Cell. Biol. 18:1998;5073-5081.
47. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
48. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:1993;2005-2015.
49. Meyer M., Pahl H.L., Bauerle P.A. Regulation of the transcription factors NF-κB and AP-1 by redox changes. Chem.-Biol. Interact. 91:1994;91-100.
50. Morris S.L., Walsh R.C., Hansen J.N. Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. J. Biol. Chem. 259:1984;13590-13594.
51. Muller J., Rupec R.A., Baeuerle P.A. Study of the gene regulation by NF-κB and AP-1 in response to reactive oxygen intermediates. Methods. 11:1997;301-312.
52. Munoz C., Castellanos M.C., Alfranca A., Vara A., Esteban M.A., Redondo J.M., de Landazuri M.O. Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J. Immunol. 157:1996;3587-3597.
53. Nunoshiba T., deRojas-Walker T., Wishnok J.S., Tannenbaum S.R., Demple B. Activation by nitric oxide of anoxidative-stress response that defends Escherichia coli against activated macrophages. Proc. Natl. Acad. Sci. USA. 90:1993;9993-9997.
54. Nunoshiba T., DeRojas-Walker T., Tannenbaum S.R., Demple B. Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages. Infect. Immun. 63:1995;794-798.
55. Pulverer B.J., Kyriakis J.M., Avruch J., Nikolakaki E., Woodgett J.R. Phosphorylation of c-Jun mediated by MAP kinases. Nature. 353:1991;670-674.
56. Pulverer B.J., Hughes K., Franklin C.C., Kraft A.S., Leevers S.J., Woodgett J.R. Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells. Oncogene. 8:1993;407-415.
57. Rouse J., Cohen P., Trigon S., Morange M., Alonso-Llamazares A., Zamanillo D., Hunt T., Nebreda A. A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 78:1994;1027-1037.
58. Rupic R., Baeuerle P.A. The genomic response of tumor cells to hypoxia and reoxygenation. Differential activation of transcription factors AP-1 and NF-kappa B. Eur. J. Biochem. 234:1995;632-640.
59. Schenk H., Klein M., Erdbrugger W., Droge W., Schulze-Osthoff K. Distinct effects of thioredoxin and other antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA. 91:1994;1672-1676.
60. Schmidt K.N., Amstad P., Cerutti P., Baeuerle P.A. The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem. Biol. 2:1995;12-22.
61. Schmidt K.M., Traencker E.B., Meier B., Baeuerle P.A. Induction of oxidative stress by okadaic acid is required for activation of NF-κB. J. Biol. Chem. 270:1995;27136-27142.
62. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen species intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
63. Schulze-Osthoff K., Bakker A.C., Vanhaesebroeck B., Beyaert R., Jocabs W.A., Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267:1992;5317-5323.
64. Schulze-Osthoff K., Los M., Baeuerle P.A. Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50:1995;735-741.
65. 1 phase by N-acetylcysteine. Toxicol. Appl. Pharmacol. 149:1998;210-216.
66. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:1986;705-716.
67. Sen C.K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
68. Sha W.C., Liou H.C., Tuomanen E.I., Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330.
69. Sies H. Oxidative stress: from basic research to clinical application. Am. J. Med. 91:1991;315-385.
70. 2-resistant Chinese hamster fibroblasts. J. Cell. Physiol. 142:1990;255-260.
71. 2-resistant fibroblasts. Arch. Biochem. Biophys. 292:1992;221-227.
72. 2 stimulate mitogen-activated protein kinase activity in NIH3T3 cells through the formation of reactive oxygen intermediates. Cancer Res. 54:1994;12-15.
73. Storz G., Tartaglia L.A., Farr S.B., Ames B.N. Bacterial defences against oxidative stress. Trends Genet. 6:1990;363-368.
74. Sun Y., Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;335-348.
75. Sukhatme V.P., Cao X.M., Chang L.C. et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 53:1988;37-43.
76. Suzuki Y.J., Packer L. Inhibition of NF-κB activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193:1993;277-283.
77. Toledano B., Kullik I., Trinh F., Baird P.T., Schneider T.D., Storz G. Redox dependent shift of OxyR-DNA contacts along an extended DNA-binding site: a mechanism for differential promoter selection. Cell. 78:1994;897-909.
78. Traenckner E.B., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated from of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13:1994;5433-5441.
79. Traenckner E.B., Pahl H.L., Henkel T., Schmidt K.N., Wilk S., Baeuerle P.A. Phosphorylation of human I kappa B-alpha on serines 32/36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14:1995;2876-2883.
80. Treisman R. Journey to the surface of the cell: Fos regulation and the SRE. EMBO J. 14:1995;4905-4913.
81. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-B/IB family: intimate tales of association and dissociation. Genes Dev. 9:1996;2723-2735.
82. Walker L.J., Craig R.B., Harris A.L., Hickson I.D. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res. 22:1994;4884-4889.
83. Woodgett J.R., Pulverer B.J., Plyte S., Hughes K., Nikolakaki E. Nuclear oncoprotein targets of signal transduction pathways. Pigment Cell Res. 7:1994;96-100.
84. Weichselbaum R.R., Hallahan D.E., Fuks Z., Kufe D. Radiation induction of immediate early genes: effectors of the radiation-stress response. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;229-234.
85. Wu J., Dunham W.R., Weiss B. Overproduction and physical characterization of SoxR, a [2Fe-2S] protein that governs an oxidative response regulon in Escherichia coli. J. Biol. Chem. 270:1995;10323-10327.
86. Xanthoudakis S., Miao G.G., Wang F., Pan Y.-C.E., Curran T. Redox activation of fos-jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11:1992;3323-3335.
87. Xanthoudakis S., Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 11:1992;653-664.
88. Xanthoudakis S., Miao G.G., Curran T. The redox and DNA-repair activities of Ref-1 are encoded by non-overlapping domains. Proc. Natl. Acad. Sci. USA. 91:1994;23-27.
89. Xanthoudakis S., Curran T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv. Exp. Med. Biol. 387:1996;69-75.
90. Xia C., Hu J., Ketterer B., Taylor J.B. The organization of the human GSTP1-1 gene promoter and its response to retinoic acid and cellular redox status. Biochem. J. 313:1996;155-161.
91. Yao K.-S., Xanthoudakis S., Curran T., O'Dwyer P.J. Activation of AP-1 and of a nuclear redox factor, ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14:1994;5997-6003.
92. Zabel U., Baeuerle P.A. Purified human I-κB can rapidly dissociate the complex of the NF-B transcription factor with its cognate DNA. Cell. 61:1990;255-265.
93. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IB kinase complex (IKK) contains two kinase subunits IKK and IKKβ, necessary for IB phosphorylation and NF-B activation. Cell. 91:1997;243-252.
94. Zheng M., Aslund F., Storz G. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science. 279:1998;1718-1721.